Note: This blogpost is based only on the provided investor presentation and the Q4 FY26 earnings conference call transcript.

CareEdge ends FY26 with record profits, while building new growth lines

CARE Ratings Limited, branded as CareEdge, closed FY26 with its highest-ever profitability on both standalone and consolidated bases. Consolidated revenue from operations rose to Rs 473.07 crore, up 18% year on year. EBITDA increased to Rs 197.39 crore, up 27%, with EBITDA margin at 42%. Consolidated profit after tax came in at Rs 173.69 crore, up 24%, with PAT margin at 33%.

Standalone performance remained strong as well. Revenue from operations was Rs 387.72 crore, up 15%. EBITDA reached Rs 187.39 crore, up 21%, with a 48% margin. Standalone PAT was Rs 174.39 crore, up 18%, with a 39% PAT margin.

In Q4 FY26, momentum stayed intact. Standalone revenue was Rs 107.58 crore, up 18% year on year, with a notably high EBITDA margin of 54%. On a consolidated basis, Q4 revenue was Rs 130.67 crore, up 19%, and EBITDA margin was 46%.

A year where bank credit helped offset softer bond issuance

CareEdge’s management framed FY26 in the context of shifting fundraising patterns. Corporate bond issuance was weaker, falling 11.3% year on year in Q4 FY26 and 3.2% for full-year FY26, as per the presentation. Commercial paper issuance was largely flat in Q4 but grew 7.2% for the full year.

At the same time, bank credit growth accelerated. The presentation highlighted overall bank credit offtake growth of 16.1% in FY26 versus 11% in FY25, with industry credit growth improving to 15% and services credit growth rising to 19%.

During the concall, management explicitly pointed to this mix. The bond market saw some softness after a strong Q1, but the bank loan rating market remained buoyant as bank credit growth accelerated. Management also reiterated the annuity nature of the business, where surveillance income forms a meaningful portion of rating revenues. The company did not provide a quantitative split between initial and surveillance fees, citing client fee structures that make bifurcation difficult.

Financial summary

Segment mix: non-ratings crosses Rs 50 crore, but ratings still dominate

The consolidated segmental breakup in the presentation shows that the ratings segment remains the core driver.

• Ratings segment revenue in FY26: Rs 423.05 crore (about 89% of consolidated revenue)
• Non-ratings segment revenue in FY26: Rs 50.01 crore (about 11% of consolidated revenue)

Non-ratings grew faster in percentage terms, but the company’s ratings franchise also expanded strongly, limiting the shift in mix.

Segment snapshot

Strategy: global ratings, PaRRVA and enterprise AI

A key feature of the FY26 narrative is the company’s push to broaden its franchise beyond domestic credit ratings.

CareEdge Global IFSC

Management described CareEdge Global IFSC as having completed its first full year of operations in FY26. Highlights cited include ratings on 45 sovereigns and over USD 8 billion of corporate debt rated with 30-plus issuers across more than 10 sectors. The company also pointed to regulatory progress, including expanded RBI accreditation and an ESG ratings licence from IFSCA.

Management clarified that profitability will take time because the business is still in its early phase.

PaRRVA

The Past Risk and Return Verification Agency, conceptualized by SEBI and built in collaboration with CareEdge Ratings and NSE, was described as moving from pilot to market.

• Pilot launch: December 2025
• Commercial launch: April 2026 (as per the presentation)
• Management also referred to it going live commercially in May 2026 during the concall

CareEdge’s stated role includes refining the methodology for return calculations and disseminating validated reports through careparrva.com, under an oversight committee.

AI adoption across the group

The presentation highlighted enterprise AI adoption at 60%, and management reiterated that around 60% of employees are actively using enterprise AI tools as part of daily work. The stated intent is to enhance efficiency and turnaround time across workflows while keeping expert judgement central to rating decisions. Management also referenced responsible AI governance and security measures such as Zero Trust architecture and DPDPA compliance.

Ratings quality and regulatory relevance

In the presentation, CareEdge published 1-year stability rates for investment grade categories for a five-year window. In the concall, management added that observed default rates for top categories have been among the best in the industry and are well within RBI prescribed benchmarks. They linked this to the RBI’s revised capital charge framework, where banks are asked to align risk weights to rating performance.

This is an important part of the positioning narrative, because ratings demand can strengthen when market uncertainty rises. Management emphasized that when certainty is scarce, lenders and investors seek stronger analytical anchors.

Capital allocation: dividend raised, buyback questions remain

The board recommended a final dividend of Rs 14 per share, taking total dividend for FY26 to Rs 22 per share. Investors asked why the company has not announced a buyback given cash accumulation, but management focused its response on disciplined capital allocation and the difficulty of finding an acquisition that matches strategic fit and valuation requirements.

The company stated it is evaluating inorganic opportunities, but it will not force a transaction at elevated valuations. Management also suggested that stabilizing and turning around existing subsidiaries was a prerequisite before taking on further integration risk.

What to watch in FY27

Management’s macro view is cautious. CareEdge projected India’s FY27 real GDP growth at 6.7%, assuming crude averages around USD 90 per barrel, down from a pre-conflict estimate of 7.2%. Risks cited include the ongoing West Asia conflict, higher oil prices, potential monsoon weakness amid El Nino probability, and external pressures like a widening current account deficit.

While the company did not provide revenue or margin guidance, it stated its forward priorities clearly: deepen AI and technology capabilities, scale the international franchise, and expand non-ratings businesses through delivery and client trust.

Takeaways

CareEdge’s FY26 outcome reflects a combination of operating leverage in the core ratings business and a longer-running effort to broaden the group’s growth engines. Ratings still account for nearly nine-tenths of consolidated revenue, but non-ratings has crossed Rs 50 crore and management claims CAAPL achieved breakeven in FY26.

The strategic additions of CareEdge Global IFSC and PaRRVA indicate that the company is aiming to extend its relevance across global ratings and capital markets verification. At the same time, management’s FY27 macro stance suggests it is preparing for a more uncertain environment, where credit risk assessment quality and stakeholder trust remain the core currency.